iCAD announced Solis Mammography will be featured in the next "ProFound Insights, ProFound Impact" webinar, on Dec. 14 at 3 pm EST / 12 pm PST. Moderated by iCAD‘s President and CEO, Stacey Stevens, the event will feature an exclusive interview with Chirag Parghi, M.D., Chief Medical Officer, Solis Mammography, who will share best practices and real-world case studies demonstrating the clinical value of ProFound A, iCAD’s flagship artificial intelligence solution for breast imaging. Solis Mammography was an early adopter of iCAD’s suite of Breast AI solutions, including ProFound AI, the first solution of its kind to be FDA cleared, integrating the technology into its early detection screening platform in spring 2021. During the event, Dr. Parghi will share the company’s experience deploying this technology across its network of centers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ICAD:
- iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
- iCAD management to meet virtually with BTIG
- Google Health partnership ‘significant positive’ for iCAD, says Lake Street
- JMP views iCAD agreement with Google Health ‘very favorably’
- ICAD Rises on Cancer Imaging Deal with Google